Predicting the future with stem cells.
作者信息
Mohsin Sadia, Wu Joseph C, Sussman Mark A
机构信息
San Diego Heart Research Institute, San Diego State University, San Diego, CA (S.M., M.A.S.); and Stanford Cardiovascular Institute, Stanford University School of Medicine, Stanford, CA (J.C.W.).
出版信息
Circulation. 2014 Jan 14;129(2):136-8. doi: 10.1161/CIRCULATIONAHA.113.007045. Epub 2013 Nov 18.
Abstract
摘要
相似文献
1
Predicting the future with stem cells.
Circulation. 2014 Jan 14;129(2):136-8. doi: 10.1161/CIRCULATIONAHA.113.007045. Epub 2013 Nov 18.
2
Response to letter regarding article, "growth properties of cardiac stem cells are a novel biomarker of patients' outcome after coronary bypass surgery".
Circulation. 2014 Sep 23;130(13):e118-9. doi: 10.1161/CIRCULATIONAHA.114.010924.
3
Letter by Li and Shen regarding article, "growth properties of cardiac stem cells are a novel biomarker of patients' outcome after coronary bypass surgery".
Circulation. 2014 Sep 23;130(13):e117. doi: 10.1161/CIRCULATIONAHA.113.008500.
4
Growth properties of cardiac stem cells are a novel biomarker of patients' outcome after coronary bypass surgery.
Circulation. 2014 Jan 14;129(2):157-72. doi: 10.1161/CIRCULATIONAHA.113.006591. Epub 2013 Nov 18.
5
[Morphological predictors of postoperative remodeling of the heart in patients with ischemic heart disease].
Kardiologiia. 2007;47(8):57-9.
6
Myocardial viability and cardiac dyssynchrony as strong predictors of perioperative mortality in high-risk patients with ischemic cardiomyopathy having coronary artery bypass surgery.
J Thorac Cardiovasc Surg. 2009 Jul;138(1):62-8. doi: 10.1016/j.jtcvs.2008.11.040. Epub 2009 Feb 7.
7
Intramyocardial bone marrow stem cell transplantation during coronary artery bypass surgery: a meta-analysis.
J Thorac Cardiovasc Surg. 2011 Oct;142(4):911-20. doi: 10.1016/j.jtcvs.2010.12.013. Epub 2011 Mar 3.
8
Implantation of CD133(+) stem cells in patients undergoing coronary bypass surgery.
Can J Cardiol. 2013 Nov;29(11):1533.e1. doi: 10.1016/j.cjca.2013.02.018. Epub 2013 Apr 26.
9
Correlation of functional recovery with myocardial blood flow, glucose uptake, and morphologic features in patients with chronic left ventricular ischemic dysfunction undergoing coronary artery bypass grafting.
J Thorac Cardiovasc Surg. 1997 Feb;113(2):371-8. doi: 10.1016/s0022-5223(97)70335-0.
10
Endomyocardial biopsy foretells ventricular function recovery after coronary artery bypass grafting.
Arq Bras Cardiol. 2004 Nov;83(5):379-84; 373-8. doi: 10.1590/s0066-782x2004001700004. Epub 2004 Nov 11.
引用本文的文献
1
Angiogenic Hydrogels to Accelerate Early Wound Healing.
Macromol Biosci. 2022 Jul;22(7):e2200067. doi: 10.1002/mabi.202200067. Epub 2022 May 22.
2
Treatment of hind limb ischemia using angiogenic peptide nanofibers.
Biomaterials. 2016 Aug;98:113-9. doi: 10.1016/j.biomaterials.2016.04.032. Epub 2016 Apr 26.
3
Cardiac aging - Getting to the stem of the problem.
J Mol Cell Cardiol. 2015 Jun;83:32-6. doi: 10.1016/j.yjmcc.2015.04.008. Epub 2015 Apr 14.
4
Highly angiogenic peptide nanofibers.
ACS Nano. 2015 Jan 27;9(1):860-8. doi: 10.1021/nn506544b. Epub 2015 Jan 13.
本文引用的文献
1
Growth properties of cardiac stem cells are a novel biomarker of patients' outcome after coronary bypass surgery.
Circulation. 2014 Jan 14;129(2):157-72. doi: 10.1161/CIRCULATIONAHA.113.006591. Epub 2013 Nov 18.
2
Age-associated defects in EphA2 signaling impair the migration of human cardiac progenitor cells.
Circulation. 2013 Nov 12;128(20):2211-23. doi: 10.1161/CIRCULATIONAHA.113.004698. Epub 2013 Oct 18.
3
Rejuvenation of human cardiac progenitor cells with Pim-1 kinase.
Circ Res. 2013 Oct 25;113(10):1169-79. doi: 10.1161/CIRCRESAHA.113.302302. Epub 2013 Sep 17.
4
Abnormalities of the cardiac stem and progenitor cell compartment in experimental and human diabetes.
Arch Physiol Biochem. 2013 Oct;119(4):179-87. doi: 10.3109/13813455.2013.798334. Epub 2013 Jun 12.
5
Intracoronary delivery of autologous cardiac stem cells improves cardiac function in a porcine model of chronic ischemic cardiomyopathy.
Circulation. 2013 Jul 9;128(2):122-31. doi: 10.1161/CIRCULATIONAHA.112.001075. Epub 2013 Jun 11.
6
The roles of senescence and telomere shortening in cardiovascular disease.
Nat Rev Cardiol. 2013 May;10(5):274-83. doi: 10.1038/nrcardio.2013.30. Epub 2013 Mar 12.
7
Dissecting the molecular relationship among various cardiogenic progenitor cells.
Circ Res. 2013 Apr 26;112(9):1253-62. doi: 10.1161/CIRCRESAHA.112.300779. Epub 2013 Mar 5.
8
Type 2 diabetes restricts multipotency of mesenchymal stem cells and impairs their capacity to augment postischemic neovascularization in db/db mice.
J Am Heart Assoc. 2012 Dec;1(6):e002238. doi: 10.1161/JAHA.112.002238. Epub 2012 Dec 19.
9
Regenerating new heart with stem cells.
J Clin Invest. 2013 Jan;123(1):62-70. doi: 10.1172/JCI63068. Epub 2013 Jan 2.
10
Enhanced effect of combining human cardiac stem cells and bone marrow mesenchymal stem cells to reduce infarct size and to restore cardiac function after myocardial infarction.
Circulation. 2013 Jan 15;127(2):213-23. doi: 10.1161/CIRCULATIONAHA.112.131110. Epub 2012 Dec 5.
Zotero 插件